While accumulating evidence shows that RNF115 promotes cancer development and indicates RNF115 as a therapeutic target for cancer,[30, 42] the identification of RNF115 as an inhibitor of the trafficking and the activation of TLRs raises the caution for autoimmunity when targeting RNF115 for cancer treatment. This evidence concerns the gene RNF115 and cancer.